Cheryl Guttman Krader, BS, Pharm

Study of subjects with rare inherited form of AD shows increased retinal capillary perfusion during the presymptomatic stage.

Novel option demonstrates stable to improved visual acuity and retinal thickness

The development of a novel AI-based algorithm aims to improve risk prediction for diabetic eye disease.

Results of a prospective trial show the tool is ready for clinical use and potential deployment for remote telemedical use.

Researchers advocate for intraoperative intravitreal steroid during cataract surgery in patients with DME.

Rates of anxiety and depression increased but were not necessarily tied to disease severity

A retrospective study found that in both patients with type 2 diabetes and non-diabetics, average central macular thickness was lower in Asians than Caucasians. Why is this significant for clinicians?

Researchers find that targeted subretinal delivery of stem cell derived RPE to geographic atrophy is feasible 

Inhibition plays role in autoimmune-based inflammation; has unique mechanism of action

One biologic response modifier has indication for uveitis; several in development to gain FDA approval

FA implant effective in lowering recurrence rates through available 6, 12 months of follow-up

Investigators optimistic about sustained-release ranibizumab delivery based on phase II LADDER study

Novel local corticosteroid therapy shows positive efficacy signals, favorable safety profile says Rahul Khurana, MD.